IP Library Granted Patent US 7,041,100
Granted Patent B2
US 7,041,100 · App. 10/760,719 · Granted May 9, 2006

Method and system for selective electro-thermolysis of skin targets

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,041,100
App. No.
10/760,719
Granted
May 9, 2006
Kind
B2
Abstract

A method for non-invasive selective thermal destruction of a skin target by RF current. One or more characteristics of an RF current and a bipolar RF electrode system are determined based upon one or more features of the target in order to create in the target an average energy density exceeding 5 Joules/cm 3 but lower than a skin coagulation level. The determined electrode system is then applied to the skin and an average energy density exceeding 5 Joules/cm 3 but lower than a skin coagulation level is generated in the target.

Claims (13)

1. A method for non-invasive selective thermal destruction of a skin target by RF current comprising

(a) determining one or more characteristics of an RF current and a bipolar RF electrodes system based upon one or more features of the target in order to create in the target an average energy density exceeding 5 Joules/cm 3 but lower than a skin coagulation level; and

(b) applying to the skin the determined electrode system and generating in the target an average energy density exceeding 5 Joules/cm 3 but lower than a skin coagulation level.

2. The method according to claim 1 wherein the one or more characteristics of the RF current are selected from the group comprising (a) the RF current pulse duration, (b) the RF current frequency, (c) the distance between electrodes and (d) electrode shape.

3. The method according to claim 1 where the skin target is one of the group comprising a hair follicle, blood vessel, acne, and pigmented lesions.

4. The method according to claim 1 wherein the one or more features of the skin target are selected from the group comprising: (a) the type of target, (b) the depth of the target; and (d) the size of the target.

5. The method according to claim 1 wherein a characteristic of the RF current is the distance between the electrodes and a feature of the skin target is the depth of the skin target.

6. The method according to claim 5 wherein the distance between the electrodes is at least twice the depth of the skin target.

7. The method according to claim 1 wherein a characteristic of the RF current is the pulse duration and a feature of the skin target is the rate of cooling of the target.

8. The method according to claim 7 wherein the pulse duration is shorter than the cooling rate.

9. The method according to claim 1 wherein an average intensity of the RF energy in the skin is from about 5 to about 200 Joules/cm 2 .

10. The method according to claim 1 wherein the electrodes have a circular contact area.

11. The method according to claim 1 further comprising cooling the electrodes.

Assignments (5)
NOTICE OF SUCCESSION OF AGENCY AT REEL/FRAME 059593/0269 Recorded May 29, 2026
From: BARCLAYS BANK PLC, AS PRIOR COLLATERAL AGENT
To: HSBC BANK USA, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 075648/0952 →
RELEASE (REEL 043925 / FRAME 0001) Recorded Apr 4, 2022
From: ING CAPITAL LLC
To: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
Reel/Frame 059593/0131 →
SECURITY AGREEMENT Recorded Apr 4, 2022
From: CANDELA CORPORATION; SYNERON MEDICAL LTD.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059593/0269 →
SECURITY AGREEMENT Recorded Sep 20, 2017
From: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
To: ING CAPITAL LLC, AS COLLATERAL AGENT
Reel/Frame 043925/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2004
From: KREINDEL, MICHAEL
To: SYNERON MEDICAL LTD.
Reel/Frame 014595/0489 →